Canine lymphoma is one of the most prevalent hematopoietic malignancies in veterinary medicine and shares striking biological similarities with non-Hodgkin lymphoma in humans. Verdinexor (Laverdia-CA1 ...
Additional approvals underway in Australia, Brazil, Canada, Europe, Japan and the United Kingdom LONG BEACH, Calif., June 26, 2026 /PRNewswire/ -- Anivive Lifesciences today announced that the U.S.
Anivive converts Laverdia-CA1 to full FDA approval First FDA-approved product to validate Anivive's AI-enabled development model — from drug repurposing through clinical trial enrollment Affordable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results